InvestorsHub Logo
Followers 39
Posts 5030
Boards Moderated 1
Alias Born 04/25/2010

Re: TAZZER post# 85646

Thursday, 10/06/2016 10:33:39 AM

Thursday, October 06, 2016 10:33:39 AM

Post# of 334916

BIEL not diluting at this point


Every indication is that BIEL continues to dilute at will or at need; no evidence this activity hasn't ceased - in fact, quite the opposite.

The price is low for a plethora of reasons, dilution being one, awaiting FDA approval another, etc. I won't speculate on the FDA issue. I will say that approval is not a guarantee of sales; a lot more work will have to be done to insure approval translates into revenue. It wasn't too long ago that the FDA approved the first diet pill since phen-phen's market removal. There was great (and ultimately unfulfilled) expectations on sales. The numbers just never met expectations. It happens. The stock price went up $10 per share on the approval, but today sits right around pre-approval prices. Will be interesting to see how BIEL does if approval is announced.

As for the stock - wild predictions regarding the uptick may meet with some disappointment, largely due to the significant dilution. The upward pressure will be in some portion negated by dumping - it's just difficult to say exactly what that impact will be - but there will be some. It's one of the negative side effects of dilution. Again, we will see how it plays out if approval is granted.